These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 3419519

  • 21. Perforin hyperreleasability and depletion in cytotoxic T cells from patients with exacerbated atopic dermatitis and asymptomatic rhinoconjunctivitis allergica.
    Ambach A, Bonnekoh B, Gollnick H.
    J Allergy Clin Immunol; 2001 May; 107(5):878-86. PubMed ID: 11344356
    [Abstract] [Full Text] [Related]

  • 22. Perforin-mediated target cell lysis by cytolytic T lymphocytes.
    Tschopp J, Nabholz M.
    Annu Rev Immunol; 1990 May; 8():279-302. PubMed ID: 2188665
    [No Abstract] [Full Text] [Related]

  • 23. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.
    Cesano A, Visonneau S, Clark SC, Santoli D.
    J Immunol; 1993 Sep 15; 151(6):2943-57. PubMed ID: 8104216
    [Abstract] [Full Text] [Related]

  • 24. Fas-mediated cytotoxicity remains intact in perforin and granzyme B antisense transfectants of a human NK-like cell line.
    Montel AH, Bochan MR, Goebel WS, Brahmi Z.
    Cell Immunol; 1995 Oct 15; 165(2):312-7. PubMed ID: 7553897
    [Abstract] [Full Text] [Related]

  • 25. Primary sequence homology between the effector molecules that mediate complement and T-lymphocyte cytotoxicity.
    Lowrey DM, Rupp F, Aebischer T, Grey P, Hengartner H, Podack ER.
    Ann Inst Pasteur Immunol; 1987 Oct 15; 138(2):296-300. PubMed ID: 3496905
    [No Abstract] [Full Text] [Related]

  • 26. Structure, function and expression of murine and human perforin 1 (P1).
    Podack ER, Lowrey DM, Lichtenheld M, Olsen KJ, Aebischer T, Binder D, Rupp F, Hengartner H.
    Immunol Rev; 1988 Mar 15; 103():203-11. PubMed ID: 3292394
    [No Abstract] [Full Text] [Related]

  • 27. The role of cytoplasmic granule components in cytolytic lymphocyte-mediated cytolysis.
    Tschopp J, Nabholz M.
    Ann Inst Pasteur Immunol; 1987 Mar 15; 138(2):290-5. PubMed ID: 3111498
    [No Abstract] [Full Text] [Related]

  • 28. Transgenic control of perforin gene expression. Functional evidence for two separate control regions.
    Lichtenheld MG, Podack ER, Levy RB.
    J Immunol; 1995 Mar 01; 154(5):2153-63. PubMed ID: 7868890
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A central role of perforin in cytolysis?
    Podack ER, Hengartner H, Lichtenheld MG.
    Annu Rev Immunol; 1991 Mar 01; 9():129-57. PubMed ID: 1910674
    [Abstract] [Full Text] [Related]

  • 31. A perforin-like protein from a marine mollusk.
    Mah SA, Moy GW, Swanson WJ, Vacquier VD.
    Biochem Biophys Res Commun; 2004 Apr 02; 316(2):468-75. PubMed ID: 15020241
    [Abstract] [Full Text] [Related]

  • 32. Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control.
    Pardo J, Balkow S, Anel A, Simon MM.
    Eur J Immunol; 2002 Oct 02; 32(10):2881-7. PubMed ID: 12355441
    [Abstract] [Full Text] [Related]

  • 33. Purification and characterization of lymphocyte chymase I, a granzyme implicated in perforin-mediated lysis.
    Woodard SL, Fraser SA, Winkler U, Jackson DS, Kam CM, Powers JC, Hudig D.
    J Immunol; 1998 May 15; 160(10):4988-93. PubMed ID: 9590247
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Channel-forming activity of the perforin N-terminus and a putative alpha-helical region homologous with complement C9.
    Persechini PM, Ojcius DM, Adeodato SC, Notaroberto PC, Daniel CB, Young JD.
    Biochemistry; 1992 Jun 02; 31(21):5017-21. PubMed ID: 1599928
    [Abstract] [Full Text] [Related]

  • 38. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML, Kanavaros P, Wechsler J, Casiraghi O, Gaulard P.
    J Pathol; 1997 Dec 02; 183(4):432-9. PubMed ID: 9496260
    [Abstract] [Full Text] [Related]

  • 39. Role of perforin in lymphocyte-mediated cytolysis.
    Yagita H, Nakata M, Kawasaki A, Shinkai Y, Okumura K.
    Adv Immunol; 1992 Dec 02; 51():215-42. PubMed ID: 1502975
    [No Abstract] [Full Text] [Related]

  • 40. Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege.
    Apte RS, Sinha D, Mayhew E, Wistow GJ, Niederkorn JY.
    J Immunol; 1998 Jun 15; 160(12):5693-6. PubMed ID: 9637476
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.